Shorts

Supporting Families Requires Recognizing the Full Financial Impact of Pediatric Cancer: Cherie Daly, MD

Policy, Technology Misalignment Slows NSCLC Genomic Testing: Robert Kratzke, MD

Long-Term Follow-Up Needed to Assess Axatilimab’s Bone Health Effects in Chronic GVHD: Amandeep Salhotra, MD

Human-Centered Approach Needed to Reduce Pediatric Cancer Financial Toxicity: Danielle Fragalla, MSE

The Future of Cell Therapy: Beyond Current Limitations: Muhammad Bilal Abid, MD

Health Plan Policies Can Expand Access to Pharmacy-Based Contraceptive Care: Sally Rafie, PharmD

How the OCM Reshaped Oncology Practice Conversations: Kathy Oubre, MS

Building the Ideal CRM Care Team: Sheng Fu, MD

The Evolution & Risk of Modern Cell Therapy: Muhammad Bilal Abid, MD

Next Steps After Negative Biomarker Testing in NSCLC: Robert Kratzke, MD

Care Management Is the Future of Oncology: Stephen Schleicher, MD, MBA

4 Strategies to Protect Severely Immunocompromised Patients: Muhammad Bilal Abid, MD

The Advent of the OCM: Stephen Schleicher, MD, MBA

Sleep Apnea is Underdiagnosed, But Treatment is Covered: Martin Hopp, MD, PhD

Why You Should Be Getting a 12-Month Supply of Birth Control: Sally Rafie, PharmD

The Rules for IVIG Replacement Therapy: Muhammad Bilal Abid, MD

What It's Really Like Living With Severe Nasal Polyps: Joseph K. Han, MD

Multidisciplinary Care, Early Detection Key to Managing Immunotherapy Effects in Melanoma: Igor Puzanov, MD, MSCI, FACP

Defining Intermediate vs High-Risk Immunocompromised Patients: Muhammad Bilal Abid, MD

How States Are Increasing Access to Contraception: Sally Rafie, PharmD

Preserving Muscle Mass Is Essential When Treating Patients With Tirzepatide: Sandra Chaparro, MD

Is CPAP the Only Option for Sleep Apnea?: Kate Willis

Melanoma Survival Gains Highlight Next Frontier in Immunotherapy: Igor Puzanov, MD

How Doctors Stratify Infection Risk in Patients: Muhammad Bilal Abid, MD

EHA 2026 Highlights Include Advances in Pediatric ALL, Immunotherapy: Shannon L. Maude, MD, PhD, and Martin Schrappe, MD, PhD

The Fundamental Immune Paradox of Cancer Therapy: Muhammad Bilal Abid, MD

Improving Clinical Thresholds for Patient Health Outcomes: Samuel Shangwu Wu, PhD

Can Oral Ketones Treat Diabetic Heart Failure?: Anne Komé, PharmD

Better Early-Onset CRC Survivorship Care Hinges on Cardiometabolic Risk Understanding: Meng-Han Tsai, PhD

Why Visceral Fat Loss Matters More Than Muscle: Lee Kaplan, MD, PhD